SLCTR/2007/005Completed未知
Study on infusion rate of snake antivenom therapy
IRQUE Project0 sites206 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 206
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Patients with a possible clinical diagnosis of a snakebite
Exclusion Criteria
- •* Under 14 years of age * Pregnant ladies * Previous administration of antivenom * Refusal of consent
Investigators
Similar Trials
Completed
Phase 2
Clinical Trial of a new snake antivenom for the treatment of viper snake bites in Sindh.treatment of envenomation.Toxic effect of snake venomIRCT2014070218314N1Department of health, Governement of Sindh12
Completed
Not Applicable
The study about appropriate infusion rate of rocuronium under geneal anesthesia.general anesthesiaJPRN-UMIN000012313Department of anesthesiology, Kagoshima university hospital40
Active, not recruiting
Phase 1
Study to assess the optimum dose of intravenous adenosine in the assessment of fractional flow reserve - Pressure Wire StudyTo study the effects of higher dose adenosine on intermediate coronary lesions at coronary angiography which require pressure wire study.EUCTR2007-001916-22-GBCentral Manchester and Manchester Children's Hospital University NHS Trust
Not yet recruiting
Phase 4
Clinical study of snake antipruritic pills in the treatment of chronic spontaneous urticariaChronic spontaneous urticariaITMCTR2200005651guangdong Provincial Hospital of Chinese Medicine
Recruiting
Unknown
Clinical implementation of the infusion rate individualization of intravenous lipid emulsioJPRN-UMIN000054236Kobe Gakuin University120